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Abstract
Microfluidic lab-on-a-chip (LOC) technologies have been developed as a promising
alternative to traditional  central  laboratory-based analysis  approaches over several
decades  due  to  the  capability  of  realizing  miniaturized  multiphase  and multistep
reactions. In the field of nucleic acid (NA) diagnosis, digital NA detection (dNAD) as a
single-molecular-level detection is greatly attributed to the perfect combination of NA
amplification and microfluidic LOC techniques. In this chapter, the principle, classifi‐
cation, advances, and application of dNAD will be involved. In particular, the focus will
be on chip-based dNAD for giving a deep interpretation of the analysis and evalua‐
tion of digital detection. The future prospect of dNAD is also anticipated. It is sure that
dNAD by means of microfluidic LOC devices as the promising technique will better
serve the ambitious plan of precision medicine through absolute quantitation of NA
from individuals.
Keywords: digital nucleic acid detection, lab-on-a-chip, microfluidic chip, digital
PCR, quantitation
1. Introduction
It has been clearly investigated that nearly all of the diseases possess a series of biomarkers
associated with nucleic acid (NA) molecules during the development of biological researches
[1–5]. Determining these NA molecules and their intercellular and extracellular changes is a
well-worked strategy for estimating therapy efficacy, monitoring minimal residual diseases,
unveiling the mechanisms of cellular signal transduction, and so on [6–8]. To reflect individu‐
al genetic differences, single-molecule level quantitation of NAs has been increasingly con‐
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
cerned recently due to its superiority on analytical sensitivity and accuracy [9, 10]. Furthermore,
single NA molecule detection is also highly preferred as the calibration strategy for next-
generation sequencing (NGS) to better serve recently proposed ambitious plans of precision
medicine [11–13]. Thus, testing NAs, especially in single-molecule level, plays an essential role
in modern biological researches and diagnosis fields.
At present, the widely used approaches in detecting NA molecules are quantitative polymer‐
ase chain reaction (qPCR) and quantitative reverse transcription-PCR (qRT-PCR). Apart from
the capability of real-time monitoring the amplification, they can be applied to quantify the
target NA molecules through two common strategies: relative quantification and absolute
quantification. The former is based on internal reference genes (namely, housekeeping genes)
to normalize and reflect fold differences in expression levels of mRNA, which is commonly
interpreted as cDNA [14, 15]. The latter can provide the exact number of targeted molecules
using an established standard curve of the change in quantification cycles with known
molecule number of NA standards [16–19]. However, qPCR is compromising the ability of
single-molecule quantitation analysis [20, 21]. Alternatively, when PCR meets microfluidic or
nanofluidic chips, a highly sensitive NA quantification technique [digital PCR (dPCR)]
emerges, estimating NAs advantageously at a single-molecule analysis level [22].
At the end of 20th century, the first concept of dPCR was proposed by Vogelstein and Kinzler
[23]. Since the concept was proposed, many dPCR platforms have been launched for several
Figure 1. Some vendors and their launched microfluidic chips and dPCR devices. The pictures are all from the web‐
sites of the corresponding companies or reprinted with permission from Ref. [59]. © Copyright 2011 American Chemi‐
cal Society.
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decades based on differently designed microsystems, including femtoliter array, spinning
disk, SlipChip, droplet, microfluidic formats, and so on [24–30]. Some even have been
successfully paced into industrial phase because of the superiority of testing and the promising
application. Currently, several vendors in the biological industry, such as Fluidigm, Bio-Rad
Laboratories, Life Technologies (ThermoFisher), RainDance Technologies, and Formulatrix,
have launch individually their commercialized dPCR devices (Figure 1).
Apart from dPCR, digital isothermal NA amplification (dINAA) devices also arouse great
concern. Unlike dPCR, dINAA leans on the isothermal NA amplification, which can be carried
out at a consistent temperature, obviating the requirement of highly stable thermocycling
devices. Thus, when targeting practical point-of-care testing (POCT) devices, dINAA is
superior to dPCR. However, viewed from the principle of realizing digital detection, the
concept of dINAA is the same as that of dPCR, just replacing PCR with isothermal amplifica‐
tion. In particular, due to loop-mediated isothermal amplification (LAMP) displaying as the
best promising method among a lot of isothermal NA amplifications, digital LAMP (dLAMP)
is the first dINAA developed [31, 32]. Later, other dINAAs have been reported, such as digital
multiple displacement amplification (dMDA), digital isothermal multiple-self-matching-
initiated amplification (dIMSA), digital recombinant polymerase amplification (dRPA), and
so on [33–38]. However, the development of dINAA devices is still in the research stage, as
the commercial products have not been launched yet.
As of now, more and more researchers are enthusiastic about the potential of digital NA
detection (dNAD) based on microfluidic Lab-on-a-Chip (LOC) devices, since an increasingly
significant role has been played in single-cell analysis, early diagnosis of cancer, prenatal
diagnosis, and so on. In this chapter, we will concentrate on the principle, classification and
advances, analysis and evaluation, application, and future prospects of dNADs that are
accomplished either through commercialized LOC devices or the devices our laboratory or
other laboratories have established.
2. Principle of dNAD
According to the strategies of amplifying NA, dNAD or single-molecule NA detection can be
divided into dPCR and dINAA. However, both of them share the same principle.
Generally speaking, the principle of dNAD is composed of three core steps [39]. First, the
original sample should be partitioned into thousands or hundreds of thousands of individual
microreactions, endeavoring to make each contain nearly one target molecule. Second, the
number of “positive” microreactors indicated either in a real-time reaction or in an endpoint
reaction is counted and analyzed. Third, the concentration of nonpartitioned sample is
calculated using certain statistical methods. In theory, if the number of microreaction is more
enough or the number of target molecules is less enough, one reaction unit with positive signal
represents one target molecule. However, in fact, a positive partition may contain more than
one molecule. Therefore, in calculating the target’s true concentration, a Poisson distribution
is adopted in hope to correct the results. Therefore, dNAD can be considered as a binary output
(present or absent like “1” or “0” in computer science) measurement, giving a direct and high-
Digital Nucleic Acid Detection Based on Microfluidic Lab-on-a-Chip Devices
http://dx.doi.org/10.5772/62742
127
confidence NA molecule’s measurement method [10, 40]. Compared to conventional tube-
based NA detection, digital analysis is superior in realizing the absolute quantification with
high sensitivity, high precision, and low ambiguity, avoiding the requirement of establishing
a standard curve.
3. Classification and advances of dNAD
In the early stage of digital detection, the used materials are 96- and 384-microwell plates. Then,
due to the rapid development of microfluidic chip techniques, an increasing number of digital
detection devices emerge. Also, a variety of materials have been used individually or jointly,
such as silicon wafer, quartz, glass, polydimethylsiloxane (PDMS), polymethyl methacrylate,
and so on. According to the approaches to partition reaction mixture, the currently launched
dNAD methods can be roughly grouped into three categories: plate-based dNAD (pdNAD),
droplet-based dNAD (ddNAD), and chip-based dNAD (cdNAD). On structural design, each
classified dNAD has the advantages and disadvantages, and the corresponding commercial
devices are also developed. In this subchapter, we are going to narrate their features and recent
advances in either commercial or research aspects.
3.1. pdNAD
At present, most of the pdNADs are established as dPCR devices, but they are not hard to be
developed as dINAA platforms. As the first generation of dNAD, plate-based dPCR (pdPCR)
was first conducted using plenty of commercially available 96- and 384-microwell plates [23,
41]. The biggest benefit for this kind of digital platform is saving to create the plates that have
been widely used in conventional PCR. Each microwell undertakes each microreaction;
therefore, the high sensitivity and accuracy of detection lean entirely on the enough number
of microwells. However, actually, the number is hard to be reached just using microwell plates.
Another problem causing the embarrassment is the volume of reagents required [42]. For each
microwell, more than 5 μL are needed, and the cost of reagents inevitably daunts most
researchers, let alone the application for POCT. To break the barriers, some researchers made
modification. As shown in Figure 2, Morrison et al. deceased the volume of microreaction into
33 nL using a stainless steel plate (25 mm in width and 75 mm in length) in which up to 3072
microholes (320 μm in diameter) were created [43]. In contrast, the required volume was
reduced to 1/64, and the throughput was increased by 24-fold, although it had the comparable
sensitivity to the past. At present, this technique has been applied to commercial devices in
2009, the OpenArray RealTime PCR System from Life Technologies. However, as the number
of reaction units increases, the problem turns into how to efficiently load the reagents.
Consequently, it has to use some ancillary equipment-like microarray spotter or mechanical
arms, which in turn raises the cost and is cumbersome.
Considering the embarrassing situation, in the second half of 2013, Life Technologies launched
the next-generation digital detection device, the QuantStudio 3D dPCR system [42, 44]. It is a
simple and affordable platform to provide the reliable and robust dPCR. The device used a
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special plate (10 mm in width and 10 mm in length) where a total of 20,000 hexagonal micro‐
wells are fabricated. The volume of each microwell is 0.8 nL, and each reaction well is isolated
absolutely from its neighbors. At present, the system has been applied to the absolute quan‐
tification of viral load, low-level pathogen detection, sensitive genetically modified organism
(GMO) detection, differential gene expression, copy number variation (CNV), NGS library
quantification, and rare mutation analysis [45–50]. Although the cost of reagents is reduced,
the system still calls for supporting instruments to load the reagents, amplify the sample, and
read the results.
For high-throughput sample analysis, 96- and 384-microplate formats are still of use. Formu‐
latrix introduced a new commercial high-throughput pdPCR device termed as constellation
dPCR. The device brings the digital analysis to a 96-sample microplate format, and the so-
called high-throughput results from the preformation of dPCR on 96 samples at once and up
to 384 samples per hour. As required, the number of partitions for each microwell in the plate
can be easily increased, and it reaches 496 for the 96-microplate format.
3.2. ddNAD
ddNAD can go back to emulsion PCR (ePCR) [51–54]. ePCR is widely used for NGS (Figure
3) [55]. After generating a DNA library, the fragments of genomic DNA are attached to the
beads, because their surface is modified with oligonucleotide probes whose sequences are
complementary to the sequences of the fragments. When the beads are compartmentalized
into water (the PCR reagent)-oil emulsion droplets, plenty of microreactors are produced. Since
each bead captures single-stranded DNA fragment, in theory, ePCR can amplify it down to
one DNA molecule. However, it is not easy to partition the fragments and beads into one
Figure 2. Plate-based chip used for the OpenArray RealTime PCR System. A rectilinear array of 3072 microholes with
320 μm in diameter was fabricated in a stainless steel plate (25×75×0.3 mm). The volume of each hole was approximate‐
ly 33 nanoliers, and to match the pitch of the wells in a 384-well microplate, the 48 groups of 64 holes are spaced at 4.5
mm. Reprinted with permission from Ref. [43]. © Copyright 2006 Oxford University Press.
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droplet simultaneously, and then the performance of ePCR suffers from variety. Benefitting
from the rapid development of microfluidic LOC techniques, ddNAD also enjoys a huge boom
in recent years. dPCR is still the main part in ddNAD, but droplet-based dINAAs including
dLAMP, dRPA, digital rolling circle amplification (RCA), and digital hyperbranched RCA
(HRCA) are showing up more and more [34–37, 56].
Figure 3. ePCR used for NGS. Top left: The genomic DNA is isolated, fragmented, ligated to adapters, and separated
into single strands. Top right: Fragments are bound to beads that are captured in the droplets of a PCR mixture-in-oil
emulsion. Then, ePCR occurs within each droplet. Bottom right: After breaking emulsion and denaturing the DNA
strands, beads with single-stranded DNA are deposited into wells of a fiber-optic slide. Bottom left: Pyrophosphate
sequencing is initiated within each well after depositing smaller beads carrying immobilized required enzymes. Re‐
printed with permission from Ref. [55]. © Copyright 2005 Nature Publishing Group.
Beer et al. successfully created picoliter-scale water-in-oil droplets by using a shearing T-
junction in a fused-silica device in 2008 [57]. The NA used for the device was RNA; therefore,
an off-chip valving system was integrated to stop the droplet motion, because a different
thermal cycling was required for reverse transcription and subsequent PCR amplification.
Each droplet contained the PCR mixture of single-copy template, primers, and reaction buffer,
which was really termed as digital detection. One year later, Mazutis et al. developed a method
for high-throughput dINAA platform in a 2 pL droplet-based microfluidic system [35]. The
isothermal HRCA was used to perform the DNA amplification in droplets. This platform was
demonstrated to allow fast and accurate digital quantification of the template. In 2011, Zhong
et al. reported another picoliter-scale droplet-based multiplexing dPCR platform, breaking the
one target per color barrier of qPCR [58]. The number of droplets generated reached more than
106, which was enough for enhancing the likelihood that only one DNA molecule was
amplified in each droplet. Given its great potential in application, RainDance Technologies
launched the commercial digital detection system with the highest droplet throughout, the
RainDrop dPCR system. Unfortunately, the system may consume up to 50 μL reagents per
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sample. Considering this point, the system may be not proper for rare sample detection. At
the same year, Hindson et al. also established a high-throughput droplet-based dPCR (ddPCR)
platform [59]. A total of 2 million droplets were generated, and the droplets were then
transferred into a 96-well plate for TaqMan probe-based PCR. Finally, to read out the results,
a flow cytometry-like double-channel fluorescence detection device was used in a microfluidic
chip, in which droplets went through one by one. The platform was confirmed to realize the
accurate measurement of germ-line CNV, discriminate the mutant molecules from the wild
molecules with 105-fold excess, and absolutely quantify circulating fetal and maternal DNA
from cell-free plasma. Based on the platform, the first commercial ddPCR system was launched
by QuantaLife in 2011, but in the end of that year Bio-Rad Laboratories purchased the company
and launched the QX100 ddPCR. Recently, the new version, QX200 ddPCR system, is also
available.
Apart from the process of droplet generation and subsequent NA amplification, other
approaches to generate droplet are also reported. As shown in Figure 4, Shen et al. described
a SlipChip to create droplet array [26]. The SlipChip was composed of two glass plates, in
which elongated wells were designed to overlap and form the fluidic path for reagent loading.
After sample loading, the simple slipping of the two plates broke the path, removing the
overlap among wells and generating 1280 droplet array (2.6 nL for each). The device had a
reservoir preloaded with oil, so each microreactor was absolutely isolated from each other
Figure 4. Design and mechanism of the SlipChip for dPCR. The top plate is outlined with a black solid line, the bottom
plate is outlined with a blue dotted line, and red represents the sample. (a) Schematic drawing shows the design of the
entire assembled SlipChip for dPCR after slipping. (b) Schematic drawing of part of the top plate. (c) Schematic draw‐
ing of part of the bottom plate. (d–f) The SlipChip was assembled such that the elongated wells in the top and bottom
plates overlapped to form a continuous fluidic path. (g–i) The aqueous reagent (red) was injected into SlipChip and
filled the chip through the connected elongated wells. (j–l) The bottom plate was slipped relative to the top plate such
that the fluidic path was broken up and the circular wells were overlaid with the elongated wells, and aqueous drop‐
lets were formed in each compartment. (d, g, and j) Schematic of the SlipChip. (e, h, and k) Zoomed-in microphoto‐
graph of the SlipChip. (f, i, and l) Microphotograph of the entire SlipChip. Reprinted with permission from Ref. [26]. ©
Copyright 2010 Royal Society of Chemistry.
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during thermal cycling. Finally, the results were read out using endpoint fluorescence
intensity. The biggest advantage of SlipChip is the capability of realizing multistep manipu‐
lation of plenty of microvolumes to form droplet array in parallel. Attributed to the remarkable
feature, until now, the SlipChip has been applied to perform immunoassays, protein crystal‐
lization, multiplex PCR, dPCR, dLAMP, dRPA, and so on [26, 34, 60–64].
To make the droplet more stable and to easily collect the amplified products, Leng et al.
invented an agarose droplet-based single-molecule ePCR device [51]. The agarose performed
the unique thermoresponsive sol-gel switching property, and a microfluidic chip was designed
to produce uniform agarose solution droplets. Schuler et al. applied centrifugal step emulsi‐
fication to the fast and easy generation of monodisperse droplets [37]. Only by adjusting the
nozzle geometry (depth, width, and step size) and interfacial tensions droplets with desirable
diameters could be produced. Using this droplet device, dRPA was successfully established
for the absolute quantification of Listeria monocytogenes DNA concentration standards within
30 min.
In ddNAD, the microreactors are generated by carefully titrating emulsions of water, oil, and
chemical stabilizer; therefore, there is no requirement of the walls of microwells to separate
the microreactors. Compared to pdNAD, ddNAD can easily achieve higher throughput via a
microdroplet generator to produce hundreds of thousands of droplet reactions per sample.
However, the workflow of ddPCR is complicated, referring to generating droplet, transferring
droplet, sealing microplate, conventional PCR, and reading out the signal by other devices.
3.3. cdNAD
The development of cdNAD is greatly attributed to the rapid progress of microfluidic
techniques, which can realize the low cost, low volume, and high-throughout paralleled NA
detections. In the last several decades, microreactors in cdNAD are mainly formed either by
the mechanical compartmentalization of PDMS or by the succeeding isolation via immiscible
liquid phase. In particular, for PDMS-based chips, the establishment of multilayer soft
lithography (MSL) techniques developed by Unger et al. in 2000 also gives a huge boost,
making the high-density microwells, micropumps, and microvalves easily fabricated [65].
Based on different power sources to partition reagents, cdNAD can be divided into three
categories: integrated fluidic circuit (IFC) cdNAD, self-priming compartmentalization (SPC)
cdNAD, and localized temporary negative pressure (LTNP)-assisted cdNAD as well as other
cdNADs.
3.3.1. IFC cdNAD
The outstanding feature of IFC chip is the special design of separated and interlaced liquid
and gas channels, as shown in Figure 5. Taking advantage of the high elasticity of PDMS,
hundreds or thousands of microreaction units are formed rapidly when gas channels are added
with pressure.
In 2006, Ottesen et al. used the IFC chip to achieve dPCR analysis [66]. A total of 1176 micro‐
reaction units were produced by controlling accurately the integrated microvalves and
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removing the conventional microarray spotter and plates. Now, the IFC chip-based dPCR (IFC
cdPCR) platform is successfully established for commercial purpose by Fluidigm. As the first
vendor to commercialize dPCR device, Fluidigm provides two IFC-based systems, the
BioMark HD and EP1 systems. In the two systems, the PCR reagents are mixed and partitioned
automatically, the thermocycling is integrated, and the results can be read out after reaction.
The BioMark HD system can offer real-time detection for each tiny reaction and eliminate false
positives according to the data, so the system is also available to qPCR. Compared to BioMark
HD, EP1 is just an endpoint detection machine, giving the binary output-like data whether or
not the microreaction occurs. Recently, Fluidigm also combines with Olink to detect human
protein biomarkers based on proximity extension assay (PEA) technology. Until now, the
dPCR device from Fluidigm has been applied to single-cell analysis, early diagnosis of cancer,
and prenatal diagnosis.
In 2011, Heyries et al. developed a megapixel dPCR platform in which 106 microunits were
fabricated, and the microreaction’s volume reached down to 10 pL (Figure 6) [67]. The density
of the microreactors reached up to 440,000/mm2, which was the highest density for IFC
platform. On detection performance, this device was able to discriminate one mutant molecule
from 105 wild molecules and achieve the discrimination of a 1% difference in chromosome
copy number. After the platform, in 2012, Men et al. published anther dPCR platform pos‐
sessing the lowest volume (36 fL) of microreactors until now. Its density of microreactors was
more than 20,000/mm2 [24]. After loading the reagents into all microreactors simultaneously,
the deformation of a PDMS membrane was used to completely seal the filled microreactors.
Due to the femtoliter-level microreactors fabricated, the device can greatly reduce the con‐
sumption of reagent and sample.
Figure 5. An IFC chip-based 12×765 digital array from the Fluidigm. Left: Schematic diagram of a part of the IFC chip
in which microchambers were connected and isolated by fluidic channels and pressure lines. Right: Optical microscop‐
ic images of the part. Reprinted with permission. © Copyright 2009 Springer.
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Figure 6. Schematic of megapixel dPCR device (a) and the layered device structure (b). Reprinted with permission
from Ref. [67]. © Copyright 2011 Nature Publishing Group.
For dINAA, IFC chip is also combined with isothermal MDA to develop dMDA for enumer‐
ation of total NA contamination [33]. On detection of microbial genomic DNA fragments,
dMDA performs higher sensitivity with orders of magnitude than qPCR.
By making the microchamber smaller or increasing its number, IFC cdNAD has a potential to
be developed into a digital detection platform with higher throughout, higher density, and
higher discrimination ability, but this platform still relies on the control system of integrated
microvalves and micropumps to load and partition the reagents, which is hard to be applied
towards POCT. Furthermore, narrowing the size of microchamber endlessly may have an
impact on the efficiency of NA amplification.
3.3.2. SPC cdNAD
Targeting practical POCT devices, currently proposed plate-based, droplet-based, and IFC
cdNADs are confronted with the huge challenge of demand for peripheral control instrument,
for instance, external syringe pumps, droplet generation devices, and plenty of integrated
microvalves and micropumps. Upon this challenge, the built-in power-driving, self-partition‐
ing, easy-to-use, and low-priced SPC cdNADs were developed by our laboratory. The built-
in power results from the gas solubility and permeability of PDMS, because PDMS remains
absorbing gas and letting gas go through them, although PDMS is in a solid state in chips [68].
The chip possesses the prominent feature of SPC, resulting from the used material of silicone
elastomer PDMS, a relatively cheap material, which possesses high gas solubility and perme‐
ability. When the fabricated chips are evacuated, a negative pressure environment is formed
due to the gas solubility of PDMS, which can service as a self-priming power to let the sample
solutions be sucked into each reaction chamber and sequentially the biocompatible oil to seal
and separate each filled chamber. Thus, in realizing dNAD, thousands of independent
microwells can be created automatically, avoiding the external control system, which is
superior to IFC cdNAD. Currently, SPC cdPCR and dINAAs [SPC chip-based dLAMP
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(cdLAMP) and SPC chip-based dIMSA (cdIMSA)] have been developed by our laboratory [30,
31, 69, 70].
3.3.2.1. SPC cdPCR
The chip shown in Figure 7 is composed of three PDMS layers, two glass coverslips, and a
waterproof layer [30]. The three PDMS layers include an inlet and outlet layer, a microwell
array layer, and a blank layer. In the microwell array layer, a total of 5120 reaction microwells
(150 μm in width, 150 μm in length, and 250 μm in height) are equally distributed in four
separate panels. Each microwell contains down to 5 nL solution. The inlet and outlet layers
have four 0.5-mm holes and four 2.5-mm holes in diameter punched as injection ports and
suction chambers when aligning to the outlet of the microwell array layer, respectively. For
mechanical stability, the blank layer coats the microwell array layer with the waterproof layer
embedded. The waterproof layer is made of low permeability fluorosilane polymer, which
beneficially prevents the evaporation during the step of denaturing template DNA at 95°C in
PCR. One of the glass coverslips with plasma pretreated are used to seal the microwell array,
and the other one is pressed on the upper surface of the SPC chip for mechanical stability at
the end of microchip operation.
MSL techniques are used to fabricate the SPC chip. The chip patterns are designed by a software
of CorelDRAW X4 and printed on transparency films using a high-resolution printer to create
Figure 7. (A) Schematic diagram of the layered device structure of the SPC chip. (B) Photograph of the prototype SPC
cdPCR device. The size of the chip is 50×24×4 mm. (C) Principle and operation procedure of the SPC microfluidic de‐
vice. The red cuboids (150×150×250 μm) stand for the microwells. Reprinted with permission from Ref. [30]. © Copy‐
right 2014 Royal Society of Chemistry.
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the masks of channels and microwells. The photoresist material used are SU8 serials, which
are a high-contrast, epoxy-based negative photoresist. Several 4-inch silicon wafers are
adopted as the mold substrate. The PDMS to replicate the SPC chip is the silicone elastomer
PDMS, which is composed of PDMS base (A) and catalyst (B) at certain ratios. Because dPCR
is an endpoint detection, the reaction components including PCR buffer, primers, labeled
probes, and templates have to be mixed before loading into the chip. Each diluted template in
the mixture is individually injected into the three panels of the chip, allowing the samples to
be compartmentalized completely and each chamber contains down to 5 nL solution. A
Maestro Ex In-Vivo Imaging System (CRI Maestro, USA) is used to capture the fluorescent
image of the microchip after dPCR. As a new generation of microfluidic chips, SPC cdPCR has
been successfully applied to the absolute quantification of β-actin DNAs and the lung cancer-
related genes.
3.3.2.2. SPC chip-based dINAAs (cdINAAs)
Although PCR is widely adopted and used as a standard analytical technique in molecular
diagnosis, it is remarkably confined when applied to field and POCT due to the facts that it
requires nonportable thermocycling facilities, its process of obtaining results is cumbersome,
and the whole amplification takes 2 h or more. Also, SPC cdPCR confronts the same defects.
Accordingly, SPC cdLAMP and SPC cdIMSA are established by our laboratory. As simple and
easy world-to-chip fluidic devices, SPC cdINAAs have the great potential in POCT for the
developing countries.
Similar to SPC cdPCR, SPC cdLAMP is also the completely valve-free and SPC device (Figure
8) [31]. It is also made mainly of PDMS and fabricated by MSL techniques. In size, the SPC
chip used for dLAMP is the same as the dPCR-used chip; however, in composition, it does not
contain a waterproof layer because of the absence of the DNA denaturing step in LAMP. For
the microwell array PDMS layer of dLAMP-used SPC chip, a total of 4800 microwells (150 μm
in width, 150 μm in length, and 300 μm in height) are fabricated and they are also equally
distributed into four panels (each contains 1200 chambers), and the interval for two closed
chambers is 150 μm. The big difference from the dPCR-used SPC is that the rectangular
chambers are located vertically on the main channels and the branch channels link to chamber
without orthogonal turning points. On performance, the SPC cdLAMP can precisely calculate
the absolute DNA concentration. To conduct the data acquisition and analysis of SPC cdLAMP,
the Maestro Ex In-Vivo Imaging System is employed. However, the imaging system is too
cumbersome and expensive to allow the e POCT, especially in the less developed regions.
Herein, an easy-to-use and cost-efficient smartphone-based dLAMP POCT device platform is
also established by our laboratory.
SPC cdIMSA is an updated version of SPC cdLAMP, in which the LAMP is replaced by IMSA
and a mixed dye is used to establish a label-free and sensitive dual-fluorescence detection for
on-chip IMSA [70, 71]. The used SPC chip for dIMSA is the same as that for dPCR without any
modifications. The SPC cdIMSA with the mixed dye for the detection of hepatitis B virus (HBV)
is conducted. In contrast, the mixed dye indicating two different colors makes it easy to count
the positive chamber number by visual inspection regardless of the cutoff values. Also, there
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is a linear response of the counted positive chamber number to the dilution ratios of templates.
Moreover, the dual fluorescence is capable of indicating more positive chamber number in
contrast to single fluorescence by SYBR Green I. The mixed dye-loaded SPC cdIMSA possesses
the advantage of enlarging the color changes over other currently used dyes or indicators.
Similarly, the mixed dye-based dual-fluorescence detection has a potential in the POCT
application of SPC cdLAMP and other SPC chip-based dINAAs.
3.3.3. LTNP cdNAD
As another POCT-oriented LOC device, LTNP chip resembling SPC chip also uses the gas
solubility of PDMS to load solution into chambers (Figure 9) [29]. However, the measure of
evacuating the LTNP chip is different from the SPC chip. For the former, the gas solubility and
permeability of the chip itself and another PDMS layer coating on the chip services simulta‐
neously as the real-time power source of evacuating with a syringe filter. For the latter,
preevacuating by a vacuum pump is indispensable, which calls for robust and efficient
approaches of sealing and packaging chips [30].
The LTNP cdPCR has been already exploited [29]. The chip consists of three parts, which are
a lamina-chip layer (LCL), a vaporproof layer (VPL), and a syringe filter-like microfluidic
device (μfilter) with helical channels. The μfilter has two parts. One is designed for generating
the LTNP through pulling the plug of the syringe connected at one end of helical channels.
The helical channel in the μfilter is 200 μm in width and 40 μm in depth. The other is used for
Figure 8. (a) Schematic diagram of the SPC chip for cdLAMP. (b) Schematic of the whole microchip and the enlarged
schematic diagram of the part of the chip, with insets showing the array and microwell geometries. It contains four
separate panels, each of which has an individual inlet and outlet. The blue lines (8×50 μm) are the flow channel. The
red spots (150×150×300 μm) stand for the microwells. Each microwell was partitioned by oil. (c) Photograph of the pro‐
totype SPC cdLAMP device. Reprinted with permission from Ref. [31]. © Copyright 2012 Royal Society of Chemistry.
Digital Nucleic Acid Detection Based on Microfluidic Lab-on-a-Chip Devices
http://dx.doi.org/10.5772/62742
137
sample and oil loading via the punched ports (0.5 mm in diameter) aligning at the ones in the
LCL. The area diameter of the region of helical channel in the two μfilters is 20 mm, covering
entirely the area of the whole chambers in the LCL. Sandwiched by the two parts of the μfilter,
LCL contains 650 chambers in a square array. The chamber is cylindrical with 200 μm in
diameter and 200 μm in depth, and the distance between two closed chambers is also 200 μm.
VPL on the LCL is also a thin circular layer with chambers at 100 mm in diameter, and its area
is 17.0 mm in diameter, entirely mulching the LCL.
Figure 9. (A) Schematic diagram of the LTNP chip. (B) Schematic of the reagent-loaded chip. It contains reagent-loaded
lamina chip (red), water-loaded VPL (blue), PDMS on the coverglass, and optical adhesive cover. (C) Digital image of
the prototype LTNP cdPCR device. Reprinted with permission from Ref. [29]. © Copyright 2015 Royal Society of
Chemistry.
Currently, LTNP cdPCR has been used for the detection of keratin 19 in A549 lung carcinoma
cells [29]. Additionally, the integrated LTNP chip with NA enrichment, isolation, and digital
detection functions has been developed and successfully applied to detect bovine DNA in
ovine meat for food adulteration detection [72, 73].
3.3.4. Other cdNADs
Gansen et al. described a self-digitization (SD) cdLAMP device shown in Figure 10 [32]. In this
device, the reagents were partitioned into the microchambers based on an inherent fluidic
phenomenon that the interplay between fluidic forces and interfacial tension could cause the
self-dispersion of an income aqueous fluid into an array of chambers prefilled with an
immiscible fluid. Therefore, the sample loading could be realized with manual or automated
syringe pumps or external air pressure, removing the hydraulic valves or mechanical action.
Less than 2 μL sample was used for the accurate quantification of relative and absolute DNA
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concentrations. To improve the efficiency of partitioning samples, a new generation of SD chip
was invented with close to 100% efficiency in 2013 [74]. In 2014, based on the SD chip, digital
RT-PCR was developed to absolutely quantify mRNA from single cells [75]. Due to the
simplicity and robustness of the SD chip, the SD cdNAD is an inexpensive and easy-to-operate
digital detection device.
Figure 10. Design of the SD cdLAMP device. (A) Schematic diagram of the individual components of a fully assembled
chip. Air pressure was delivered via a removable adapter, which was connected to an external pressure source. (B)
Layout of the microfluidic network. A dense array of rectangular side chambers was connected to a thin main channel.
The whole array was surrounded by a separate water reservoir to saturate the PDMS during incubation at 65°C. Scale
bar, 5 mm. (C) Geometry of the side chamber array and main channel. All dimensions are in micrometers. (D) Sequen‐
tial images showing the initial filling of the side-chamber array with aqueous solution. (E) Sequence of images show‐
ing the SD of aqueous sample in the side chambers. Reprinted with permission from Ref. [32]. © Copyright 2012 Royal
Society of Chemistry.
In 2010, Sundberg et al. designed a spinning disk platform to achieve dPCR [25]. The disk was
an inexpensive and disposable plastic disk-like chip. Differing from other approaches, 1000
nL microwells were generated by passive compartmentalization through centrifugation, and
the volume of each well was 33 nL in average. The whole process, including disk loading,
thermocycling, and fluorescent imaging, only costs less than 35 min. However, this kind of
cdNAD performed some defects, such as the tedious plastic disk manufacturing and the
probable NA adsorption to the disk.
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4. Analysis and evaluation of cdNAD
This part focuses on the analysis and evaluation of cdNAD. The contents involve four aspects,
which are the dehydration of microreaction, the dynamic range, the response of cdNAD, and
the precision of cdNAD.
4.1. Dehydration of microreaction
In PCR, dehydration is attributable to the repeated denaturing steps, whereas, for isothermal
NA amplification, reacting at a consistent temperature (e.g., 63°C) for at least 1 h results in
dehydration. Also, the influence of dehydration is different according to the different material-
based chips for cdNAD.
As we know, the microfluidic PDMS chips suffer from dehydration heavily. Actually, the
dehydration degree is determined by the thickness of the PDMS layer between the top of the
chamber and the waterproof layer. If v f is the total volume fraction of reaction reagent, v f is
defined by the function of
chamber chamberf
PDMS PDMS
A hv A h
×= ×
where A and h refer to the designed area and height, respectively. Using the formula of C
sat_25°C×P vap_70°C/P vap_25°C, a saturated concentration of water vapor in PDMS at 70°C (C sat_70°C) can
be calculated as 400 mol/m3. Then, the maximum fractional loss of water (fl max) from the reaction
chambers is defined by
where ρwater is the density of water and M water is the molar mass of water.
4.2. Dynamic range
When high concentration targets are loaded, the chip panel can be completely saturated,
whereas, for low targets, the chip panel still possesses the capability of realizing digital
detection. Therefore, the theoretical dynamic range is determined by the high concentrations
that make the chip completely saturated.
In this situation, the occurrence of an empty chamber is a small probability event, and due to
statistical independence between the chamber number and the total empty chamber number,
the event can be modeled as a random Poisson process. Then, the occurrence probability of t
empty chamber number, P (n=t, λ), is defined by P(n = t , λ)= λ t e −λ t !. In the function, λ equals to
the mean number of empty chambers in panels. For each empty chamber in each panel, namely,
a chamber containing 0 molecule, the probability P(n=0,λ)=e-λ=e-m/N, where λ is the ratio of the
loaded molecule number (m) to the chamber numbers (N). Therefore, λ is equal to the product
of the probability P(n=0,λ) and the N chamber numbers, namely, λ=Ne-m/N. Finally,
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P(n = t , λ)= P(n = t , N e −m/N )=(N e −
m
N )
t
e −N e −m/N / t !. If λ is more than 10, the probability of the chip
panel is completely saturated, P(n=0,λ)=e-10, which is less than 10-4 and can be as the accept‐
able failure rate. Then, λ=N e-m/N>10, and the maximum loaded molecular number (mmax) can
be calculated.
4.3. Response of cdNAD
According to the distribution of molecules across the chip, the Poisson distribution is adapted
to calculate the original concentration of target stock solution.
For each chip panel, the probability (P) of having the number (n) of NA molecules per chamber
is P(n,λ)=(λ n e -λ)/n!, where λ is the ratio of loaded molecule number to chamber number of
each panel. For λ, it is equal to the average molecule number per chamber, which can be
expressed by the equation of λ=C 0 X dil V, where C 0 is the target’s original concentration, V is
the volume of each chamber, and X dil is the dilution factor of diluted targets used in the panel.
If the stock solution is diluted in k fold, the X dil=1/k, and particularly, the X dil of stock solution
is 1. When a chamber contains 0 molecule, the probability P(n=0,λ)=e -λ. As for a chamber
capturing one or more molecules, the probability P(n≧1,λ)=1-P(n=0,λ)=1-e -λ. After dPCR, a
chamber with observed positive signal suggests that at least one target molecule is captured.
Therefore, the ratio (f) of observed positive chamber number to chamber number of each panel,
namely, the observed fraction of positive chambers, equals to the probability P(n≧1,λ), which
is f=P(n≧1,λ)=1-e -λ. Then, λ=ln(1-f)=-C 0 X dil V, and a linear variation relationship is exhibited
in terms of the regression curve equation between ln(1-f) and X dil, because C 0 and V are constant
values. Then, the target’s original concentration C 0 can be calculated based on the slope of the
curve (-C 0 V).
In addition, because the Poisson distribution is a particular case of a binomial distribution, the
distribution of the positive chamber number (x) in each panel is classified as the binomial
distribution. The probability distribution P(x) is therefore influenced by the probability
p=P(n≧1,λ)=1-P(n=0,λ)=1-e -λ. Based on the nature of binomial distribution, x is equal to the
mean, namely, x=Np=N(1-e -λ) (N, the total chamber number in each panel). Then, the average
molecule number per chamber, λ=ln{N/(N-x)}, through which the loaded molecule number
(N e) for each panel can be estimated by the equation N e=Nλ=Nln{N/(N-x)}.
4.4. Precision of cdNAD
When the chamber number in each panel is very large, the Poisson distribution is approximate
to normal distribution, which is also called Gaussian distribution. Use the parameters in the
discussion of response and dynamic range above, and let y be a random variable representing
the number of positive chambers that capture at least one molecule. Also, we can know that
its mathematical expectation or mean μ is N (1-e -λ), and its variance σ 2 is Ne -λ (1-e -λ). Then,
the probability density function associated with y is as follows:
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If the precision of cdNAD is defined as the minimum difference in concentration (∆λ/λ) that
is reliably detected with more than 99% true positive and more than 99% true negative rate,
this situation corresponds to 4.6σ separation in the mean (μ) for two Gaussian distributions.
That is to say, in the case with small ∆λ, ∆μ/∆λ=4.6σ. Then, ∂[N(1-e -λ)]∆λ/∂λ=Ne -λ∆λ=4.6[Ne -
λ (1-e -λ)]1/2, and ∆λ/λ=4.6(e λ-1)1/2/(λN 1/2). For different total chamber numbers (N) in chip panel,
the precision (∆λ/λ) to expected molecules per chamber (λ) could be plotted.
5. Application of dNAD
Compared to conventional NA detection methods, dNAD provides better sensitivity, better
precision, higher tolerance, and the NA’s absolute quantification. Until now, dNAD has been
applied to a variety of research fields, including pathogen detection, food safety, clinical
diagnosis (genetic instability estimation and early cancer), prenatal diagnosis, quantitative
analysis of gene expression, and NGS library quantification. Although dPCR is still the most
widespread type of dNAD, in resource-limited regions, it is confined due to the requirement
of thermal cycling and robust temperature control. To overcome this awkwardness, dINAAs
without thermal cycling are of great interest, which also enlarge the application of dNAD,
especially for POCT. For this subchapter, the recent advances on application of dNAD will be
narrated.
5.1. Pathogen detection
Honestly speaking, on pathogen detection, the advantages of most conventional NADs on both
analytical sensitivity and specificity are inherited by the corresponding digital formats. In
addition, dNAD has the capability of realizing NA’s absolute quantification. Therefore, dNAD
can be used as the ultrahigh sensitivity and more accurate method for viral load determination
or bacterial quantification. Kelley et al. established a duplex ddPCR assay for high-precision
methicillin-resistant Staphylococcus aureus (MRSA) analysis [76]. By assaying 397 clinical
samples, a good agreement with the reference assay for both qPCR and ddPCR assays was
indicated. Strain et al. demonstrated and estimated the application of ddPCR for a highly
precise measurement of HIV DNA [77]. Total HIV DNA and episomal 2-LTR (long terminal
repeat) circles in cells that were all isolated from infected patients were targeted. Compared
to qPCR, ddPCR performed a significantly increased precision (5-fold for total HIV DNA and
>20-fold for 2-LTR circles), making it an alternative for the measurement of HIV DNA from
clinical specimens.
dNAD also enables the direct detection without NA extraction due to the ability of partitioning
target NA and nontarget components (e.g., inhibitors) into different microwells. Pavšič et al.
employed two dPCR platforms (QX100 ddPCR system from Bio-Rad Laboratories and the
BioMark HD IFC cdPCR system from Fluidigm) for the direct quantification of two whole-
virus materials of human cytomegalovirus (HCMV) without DNA extraction [78]. It was
demonstrated that direct quantification by both dPCRs could provide repeatable measure‐
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ments of viral DNA copy numbers, giving a closer agreement with the actual viral load than
that with either dPCR or qPCR of extracted DNA.
Although dNAD certainly possesses the superiority of absolute quantitation, some reports fail
to demonstrate the advantage, which calls for the requirement of optimization when estab‐
lishing dNAD. For instance, Boizeau et al. used ddPCR to provide an absolute quantitation of
HBV genome molecules [79]. However, the results indicated that qPCR assays remained more
sensitive than ddPCR when used for low HBV DNA levels, suggesting that optimization of
ddPCR was still necessary, especially on accurately differentiating the positive from negative
in samples with very low levels of target DNA molecules.
5.2. Food safety
Food safety mainly refers to two parts: the minoring of foodborne pathogens and the detection
of GMO. For example, human noroviruses (NoV) and hepatitis A virus (HAV) are two
foodborne enteric viruses that have caused the vast majority of nonbacterial gastroenteritis or
some fatal infectious hepatitis. Coudray-Meunier et al. conducted a comparative study of IFC
RT-cdPCR and conventional RT-qPCR when quantifying the NoV and HAV from lettuce and
water samples, proving that the IFC RT-cdPCR assay was more tolerant to inhibitory sub‐
stances from lettuce samples [80]. Also, the IFC RT-cdPCR may be useful for standardizing the
quantification of enteric viruses in bottled water and lettuce samples. Fu et al. used the BioMark
HD system equipped with a 48.770 digital array to develop cdPCR for GMO detection without
pretreatment [81]. The CaMV35s promoter and the NOS terminator were selected as the
targets, and nine events of GMOs (MON810, MON863, TC1507, MIR604, MIR162, GA21, T25,
NK603, and Bt176) were collected to determine the specificity. The results showed that the
cdPCR could achieve a discrimination of down to 0.1%, lower than the labeling threshold level
of the EU, allowing highly sensitive, specific, and stable GMO screening detection. Dalmira et
al. developed a duplex ddPCR assay to characterize the certified reference materials (CRMs)
in terms of T-nos/hmg copy number ratio in maize [82]. After optimization using a central
composite design, the duplex ddPCR method realized the absolute limit of detection (LOD)
and limit of quantification (LOQ) of 11 and 23 copy number T-nos, namely, relative LOD of
0.034% and relative LOQ of 0.08%, respectively. The dynamic range of T-nos/hmg ratio ranged
from 0.08% to 100%. The results indicated that the duplex ddPCR assay was useful for
characterizing CRM candidates on T-nos/hmg ratio.
The bias caused by reliance on quantitative standards may have an impact on the results of
qPCR, which is not beneficial for water monitoring and microbial source identification.
Therefore, Cao et al. employed a duplex ddPCR to simultaneously quantify Enterococcus spp.
and the human fecal-associated HF183 marker for evaluating the water quality [83]. The results
demonstrated that ddPCR performed greater tolerance of inhibition than qPCR, with one to
two orders of magnitude higher at inhibitor concentrations. Also, ddPCR brought about
remarkably improved precision, although a lower upper LOQ than qPCR was indicated.
For food safety, it is indispensable to identify and quantify the meat products for unveiling
species fraud and product mislabeling during food processing. Tian et al. used LTNP cdPCR
to detect bovine meat in ovine meat [72]. Floren et al. successfully applied two-step ddPCR for
Digital Nucleic Acid Detection Based on Microfluidic Lab-on-a-Chip Devices
http://dx.doi.org/10.5772/62742
143
precise quantification of cattle, horse, and pig in processed meat product, with the nuclear F2
gene targeted [84].
5.3. Clinical diagnosis
At present, clinical diagnosis including genetic instability estimation and early cancer is also
the main application field for dNAD. It has been clearly confirmed that the genetic instability
of human cells is one of the causes of cancer, including somatic mutation, allelic imbalance,
loss of heterozygosity, CNVs, and single nucleotide variations (SNVs). Accordingly, how to
discriminate the rare mutant gene from abundant normal NAs attracts great concerns of
researchers. Interestingly, it is also the question that initiates the concept formation of dNAD.
As de novo CNV may be caused by reprogramming somatic cells into induced pluripotent stem
cells, Abyzov et al. used qPCR and ddPCR to detect and estimate this phenomenon. The results
showed that, in parental fibroblasts, at least half of the CNVs are indicated as low-frequency
somatic genomic variants [85]. Boettger et al. successfully applied a ddPCR approach to
analyze father-mother-offspring trios from HapMap at specific sites within region 1 on the
investigation of inference of complex CNV and single nucleotide polymorphism (SNP)
haplotypes at the human 17q21.31 locus [86].
Detecting biomarkers associated with tumor formation, development, and drug evaluations
on gene expression is the useful approach for early cancer diagnosis. Up to now, various
biomarkers have been identified, and dNAD reflects the unique advantage of absolute
quantitation of their gene expression [87]. Zhu et al. applied SPC cdPCR to the detection of
three lung cancer-related genes (PLAU, ENO2, and PLAT). cdPCR yielded comparable results
to qPCR, illustrating that the established platform had the ability of realizing absolute
quantitation for gene expression [30]. Floren et al. employed ddPCR to detect the BRAF-V600E
and V600K mutations in melanoma circulating tumor with high sensitivity [84]. The study
demonstrated that ddPCR performed 200-fold increased sensitivity than competitive allele-
specific PCR (castPCR), giving an LOD of 0.0005% when combined with whole-genome
amplification (WGA). Through noninvasive analysis of circulating free plasma DNA, Geven‐
sleben et al. determined the presence of oncogenic amplification by developing a plasma DNA
ddPCR assay targeting HER2 [88]. In the independent validation cohort, ddPCR could reach
a positive and negative predictive value of 70% and 92%, respectively. The results suggested
that ddPCR had the potential to the analysis of any locus amplified in cancer, not only in
metastatic breast cancer. Beaver et al. also employed a ddPCR assay for the detection of
circulating plasma tumor DNA (ptDNA) in patients with early-stage cancer [89]. A total of 30
tumors were first analyzed by Sanger sequencing for common PIK3CA mutations, and ddPCR
was then used to analyze their extracted DNA for the same mutations. This ddPCR-based
accurate mutation detection platform was demonstrated to be of great use for early-stage breast
cancer.
As a new generation of cancer biomarkers, abnormally DNA methylation in the gene’s
regulatory regions can affect identical residues that may cause the cancer. The analysis of
methylated genes therefore becomes more and more important in cancer research. For
example, Li et al. developed a sensitive bead-based ddPCR for the quantification of DNA
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methylation, which could detect down to one methylated DNA molecule in approximately
5000 unmethylated DNA molecules from plasma or fecal samples [20]. Weisenberger et al.
developed an improved DNA methylation detection with single-molecule high-resolution
based on IFC cdPCR and successfully identified the breast cancer-specific hypermethylation
phenomenon in the CpG islands of RUNX3, CLDN5, and FOXE1 [90].
5.4. Prenatal diagnosis
Prenatal diagnosis is usually carried out by invasive or noninvasive approaches [91]. The
invasive method (e.g., amniocentesis) refers to inserting needles into the uterus, which is time-
consuming (several weeks required) and risky to the fetus [92]. In contrast, noninvasive
method seems to be more rapid and safer. Currently, noninvasive prenatal diagnosis mainly
involves ultrasonography of the womb or detecting cell-free fetal DNA (cffDNA) in maternal
serum and plasma. The latter is also termed as noninvasive prenatal testing (NIPT). Appling
dNAD to NIPT is the emerging noninvasive approach with high sensitivity and high precision
[93–97]. Gu et al. employed the QX100 ddPCR system from Bio-Rad Laboratories to detect
cffDNA for the risk of methylmalonic acidemia, confirming that ddPCR is a cost-effective and
noninvasive prenatal method when diagnosing known mutations associated with Mendelian
disorders [98]. Pornprasert and Prasing implemented a ddPCR for the deletion of α(0)-
thalassemia Southeast Asian (SEA)-type deletion [99]. The study showed that ddPCR might
be an alternative technology to routine clinical diagnosis. Barrett et al. adopted 12×765 digital
array chips to establish an IFC cdPCR to analyze the cffDNA for NIPT of sickle cell anemia [94].
The results suggested that the built IFC cdPCR is a useful method to determine the genotype
of fetuses at risk for sickle cell anemia. Meantime, the report also illustrated that it was essential
to optimize the fractional fetal DNA concentration.
Because most cffDNA fragments were approximately 200 bp in size and, in the early gestation,
the cffDNA occupies low percentage (mostly <10%) in maternal plasma, efficient methods for
the extraction of cffDNA are in great need. Holmberg et al. thereby estimated two commercial
platforms to extract cffDNA: the Akonni Biosystems TruTip technology and the Circulating
Nucleic Acids Kit from Qiagen [100]. Determined by QX100 ddPCR system and qPCR, the
extracted products from two platforms performed similar results.
5.5. NGS library quantification
As known to all, the establishment of NGS libraries still leans mainly on manual bench-top
procedures, which is slow and inefficient [101]. To solve it, Kim et al. invented an automated
digital microfluidic LOC-based sample preparation for the NGS. Compared to the conven‐
tional methods, digital microfluidic LOC platform is cost-efficient and has high throughout
[102]. Similarly, Thaitrong et al. integrated a droplet-based microfluidic LOC system with a
unit of capillary-based reagent delivery and the quantitative CE module to develop an
automated quality-control platform for NGS [103]. Besides, White et al. confirmed that dPCR
is able to provide sensitive and absolute calibration for NGS, enabling direct sequencing
without titration runs and with sufficient precision [11]. Fu et al. developed a picoliter-scaled
droplet digital WGA (ddWGA) platform for realizing uniform and accurate single-cell
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sequencing, bringing about significantly improved amplification evenness and accuracy for
the simultaneous detection of CNVs and SNVs in single-cell level [104]. Weisenberger et al.
applied the Fluidigm BioMark Digital Array to establish digital bisulfite genomic DNA
sequencing with high resolution and high sensitivity [105]. The results showed that IFC cdPCR
was a fast and reliable method for the single-molecule-scaled detection of DNA methylation
information.
6. Conclusion and future prospects
Undoubtedly, there is growing interest in dNAD, because it allows the more precise NA
quantification, the higher discrimination of rare NA mutants, and the more reproducible and
less susceptible to inhibitors than the traditional NA methods. Consequently, dNAD has full
potential to influence the development of biology research, clinical diagnosis, the safety of food
and environment, and other research fields.
To enhance the impact of this promising technique and push it towards clinical application,
the MIQE for dNAD (dMIQE) was also published [106]. Based on dMIQE, the experimental
protocols are standardized, the efficient utilization of resources is maximized, and the data are
adequately assisted. However, the promising technique of dNAD still confronts some
shortcomings. On one hand, although the development of microfluidic LOC offers a lot of
dNAD device platforms, these devices perform low functional integration, and the supporting
detection approaches lean primarily on real-time fluorescence scanning or the endpoint
analysis of CCD camera-captured images, which, to some extent, adds the real cost and also
has impacts on the true detection accuracy. Therefore, in the future, it will become a general
trend that dNAD devices are highly integrated with multiple functions including cell or single-
cell capture, cell lysis, and NA enrichment and purification, employing more advanced
supporting detection technology. Particularly, for ddNAD, the strategy of droplet generation
is one of the developing directions. For instance, Tanaka et al. currently created a hands-off
autonomous preparation method of monodisperse emulsion droplets using a degassed PDMS
chip [107]. Jeong et al. used a specially designed three-dimensional monolithic elastomer
device to create a kiloscale droplet generation [108]. According to the snap-off mechanism,
Barkley et al. also invented a novel technique to generate monodisperse droplets [109].
On the other hand, dNAD is actually the digital version of NAD, thereby possessing the same
disadvantages (e.g., bias or nonspecific amplification) as most sequence-based NA amplifica‐
tion methods. Based on this point, how to improve or guarantee the NA amplification fidelity
in microreactors is one of the future prospects of dNAD. It should be noted that the optimized
reaction conditions for NA amplification in microreactors might be different from those in bulk
state, meaning that the optimization of reaction system is indispensable. Furthermore, the
precision of dNAD is greatly influenced by the number and size of microchambers (for
cdNAD) or droplet (for ddNAD), which in turn challenges the fabrication of microfluidic chip
and the uniformity of partitioning. Accordingly, we also anticipate that, in the future, there
will be some novel strategies developed to realize digital detection not only based on parti‐
tioning reagents.
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Certainly, the application of dNAD will be enlarged by combining with other molecular assays,
especially for single-cell analysis and single-cell genomic sequencing. For example, dNAD can
combine with proximity ligation or PEAs to achieve single-molecule protein biomarker
detection. Additionally, in the future, ongoing comparison tests of dNAD and qPCR will
roundly prove the detection superiority of dNAD in many research fields. Also, dNAD will
become the promising POCT-oriented research area for the ambitious plan of precision
medicine.
Conclusively, dNAD based on microfluidic LOC devices will continue to provide further
opportunities for determining NA molecules, protein molecules, and other biomolecules
towards deep analysis with high sensitivity and precision.
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